Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease

No Thumbnail Available

Authors

Monk, B. J.
Pujade-Lauraine, E.
Burger, R. A.

Issue Date

2013

Volume

24

Issue

Type

Journal Article

Language

Keywords

Research Projects

Organizational Units

Journal Issue

Alternative Title

Abstract

Description

Citation

Monk, B. J.; Pujade-Lauraine, E.; Burger, R. A. Integrating bevacizumab into the management of epithelial ovarian cancer: the controversy of front-line versus recurrent disease. Annals of Oncology. 2013, DEC. 24:53-58.

Publisher

License

Journal

Volume

Issue

URI

http://hdl.handle.net/10504/60561

PubMed ID

DOI

Identifier

Additional link

http://cuhsl.creighton.edu/login?url=http://kc7za5wx4c.search.serialssolutions.com/?sid=Refworks%3A&charset=utf-8&__char_set=utf8&genre=article&aulast=Monk&auinit=B.J.&title=Annals%20of%20Oncology&date=2013&volume=24&pages=53-58&issn=0923-7534&atitle=Integrating%20bevacizumab%20into%20the%20management%20of%20epithelial%20ovarian%20cancer%3A%20the%20controversy%20of%20front-line%20versus%20recurrent%20disease&spage=53&au=Monk%2CB.%20J.&au=Pujade-Lauraine%2CE.&au=Burger%2CR.%20A.&

ISSN

1569-8041
0923-7534

EISSN

Collections

Faculty Bibliography Database